查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1654281

人类偏肺病毒诊断市场规模、份额、趋势分析报告：按技术、最终用途、地区、细分市场预测，2025-2030 年

Human Metapneumovirus Diagnostics Market Size, Share & Trends Analysis Report By Technology, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 160 Pages | 商品交期: 2-10个工作天内

价格

人类偏肺病毒 (hMPV) 诊断市场的成长和趋势

根据 Grand View Research, Inc. 的最新报告，全球人类亚肺病毒诊断市场规模预计到 2030 年将达到 9.713 亿美元，2025 年至 2030 年的复合年增长率为 10.43%。

由于人类偏肺病毒 (hMPV) 引起的呼吸道感染疾病率不断上升，尤其是在儿童、老年人和免疫力缺乏低下者等脆弱人群中，人类偏肺病毒诊断市场正在经历显着增长。已知 hMPV 会引起呼吸道疾病，包括支气管炎、肺炎和上呼吸道感染疾病，类似流感和呼吸道融合细胞病毒(RSV) 引起的疾病。人们对 hMPV 在呼吸系统疾病中的作用的认识不断提高，推动了对有效诊断解决方案的需求，从而促进了市场的扩大。

该市场的主要驱动因素是诊断技术的进步、医疗保健支出的增加以及对 hMPV 感染的早期和准确检测的需求不断增长。此外，病毒性呼吸道感染疾病的增加，特别是在气候较温暖的地区，也是推动成长的一个主要因素。此外，基于 PCR 的检测、基于抗原的检测和多重 PCR 平台等快速诊断检测的持续发展，使得检测速度更快，这对于改善患者预后和抑制感染传播至关重要。

hMPV 诊断市场竞争激烈，有几家主要企业为其成长做出了贡献。主要市场参与企业包括雅培实验室、罗氏诊断、赛默飞世尔科技、生物梅里埃和西门子医疗。这些公司正在积极致力于开发新的诊断工具和平台，以更有效地检测 hMPV。策略联盟、收购和研发投资帮助我们扩大了产品系列併提高了我们的影响力。

最近的市场趋势强调了向更先进、快速和更具成本效益的诊断方法的转变，包括就地检验和能够同时检测多种病原体的多重分子检测。这些创新对于满足日益增长的高效诊断需求至关重要，尤其是在资源有限的环境中。市场也越来越注重开发能够提供更快结果的测试，以支持及时的治疗决策，这对于高风险患者群体至关重要。

hMPV 感染的盛行率在全球呈现上升趋势，尤其是在5岁以下儿童、老年人和免疫力的患者中。该病毒导致大量患者因呼吸系统疾病住院，已成为重大的公共卫生问题。准确及时的诊断对于有效管理至关重要，诊断解决方案的日益普及预计将继续塑造 hMPV 诊断市场的未来。

人类偏肺病毒诊断市场报告重点

  • 从技术角度来看，基于 PCR 的诊断领域将在 2024 年占据最大的收入份额，达到 54.97%，这得益于其高准确性、高灵敏度以及检测低病毒载量的能力。 PCR 检测能够在感染早期快速可靠地检测出 hMPV，从而加快诊断速度、改善患者预后并更有力地控制病毒传播，尤其是在高风险族群中。
  • 根据最终用途，由于对专门测试、更快的诊断结果和更准确的疾病检测的需求不断增加，诊断和参考文献实验室部分预计在预测期内以最快的复合年增长率增长。这些实验室提供识别 hMPV 和其他呼吸道感染疾病的基本服务，为临床和研究部分提供支援。
  • 根据地区，北美市场预计将主导全球市场，到 2024 年将占据 41.18% 的收入份额。这是由于人们认识度高、医疗基础设施先进以及呼吸道感染疾病盛行率不断上升。
  • 人类偏肺病毒诊断市场的竞争十分激烈。主要企业正在采取各种策略，如联盟、新产品开发、合併、收购和地理扩张，以满足客户未满足的需求。

目录

第一章调查方法与范围

第 2 章执行摘要

3. 全球人类偏肺病毒诊断市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 全球人类偏肺病毒诊断市场分析工具
    • 产业分析 – 波特五力分析
    • PESTEL 分析
    • COVID-19影响分析

第 4 章。

  • 细分仪表板
  • 全球人类偏肺病毒诊断市场技术波动分析
  • 2018 年至 2030 年全球人类偏肺病毒诊断市场规模与趋势分析（依技术分类）
  • 基于 PCR 的诊断
  • 次世代定序（NGS）
  • 萤光试验
  • 横向流动化验
  • 微阵列技术
  • 其他先进技术

5. 全球人类偏肺病毒诊断市场依最终用途、估计及趋势分析

  • 细分仪表板
  • 全球人类偏肺病毒诊断市场最终用途变化分析
  • 2018 年至 2030 年全球人类偏肺病毒诊断市场规模及趋势分析（依最终用途）
  • 医院和诊所
  • 诊断与参考实验室
  • 学术研究所
  • 其他的

6. 人类偏肺病毒诊断市场：区域、估计与趋势分析

  • 区域控制面板
  • 市场规模、预测趋势分析，2018-2030
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 公司/竞争对手分类
  • 战略地图
  • 2023 年企业市场分析
  • 主要认证提供者/计画所有者列表
  • 公司简介/上市公司
    • QuidelOrtho Corporation
    • ARUP Laboratories
    • Diasorin
    • R-Biopharm AG
    • Seegene Inc.
    • ZeptoMetrix
    • Abbott
    • Thermo Fisher Scientific Inc.
Product Code: GVR-4-68040-497-3

Human Metapneumovirus Diagnostics Market Growth and Trends:

The global human metapneumovirus diagnostics market size is anticipated to reach USD 971.30 million by 2030 and is projected to grow at a CAGR 10.43% from 2025 to 2030, according to a new report by Grand View Research, Inc. The human metapneumovirus (hMPV) diagnostics market is experiencing significant growth, driven by the increasing prevalence of respiratory infections caused by hMPV, particularly among vulnerable populations such as children, the elderly, and immunocompromised individuals. hMPV is known to cause respiratory illnesses similar to those caused by influenza and respiratory syncytial virus (RSV), including bronchiolitis, pneumonia, and upper respiratory tract infections. As awareness about hMPV's role in respiratory diseases increases, there is a growing demand for effective diagnostic solutions, contributing to the market's expansion.

Key drivers of this market include advancements in diagnostic technologies, rising healthcare spending, and the growing demand for early and accurate detection of hMPV infections. The increasing prevalence of viral respiratory infections, especially in regions with temperate climates, is also a significant factor propelling growth. Furthermore, the ongoing development of rapid diagnostic tests, such as PCR-based assays, antigen-based tests, and multiplex PCR platforms, enables faster detection, which is crucial for improving patient outcomes and controlling the spread of infections.

The hMPV diagnostics market is highly competitive, with several prominent players contributing to its growth. Key market participants include Abbott Laboratories, Roche Diagnostics, Thermo Fisher Scientific, BioMerieux, and Siemens Healthineers. These companies are actively involved in developing new diagnostic tools and platforms to detect hMPV more efficiently. Strategic collaborations, acquisitions, and research and development investments are helping them expand their product portfolios and increase their presence.

Recent market trends highlight a shift towards more sophisticated, rapid, and cost-effective diagnostic methods, such as point-of-care testing and multiplex molecular tests that can detect multiple pathogens simultaneously. These innovations are critical in addressing the growing demand for efficient diagnostics, particularly in resource-limited settings. The market is also witnessing an increased focus on developing tests that provide faster results to aid in timely treatment decisions, which is essential for high-risk patient groups.

Prevalence rates of hMPV infections are rising globally, especially in children under five years of age, as well as in the elderly and those with weakened immune systems. The virus is responsible for a substantial number of respiratory hospitalizations, making it a significant public health concern. Accurate and timely diagnosis is crucial for effective management, and the growing adoption of diagnostic solutions is expected to continue to shape the future of the hMPV diagnostics market.

Human Metapneumovirus (hMPV) Diagnostics Market Report Highlights:

  • Based on technology, PCR-based diagnostics segment held the largest revenue share of 54.97% in 2024, driven by its high accuracy, sensitivity, and ability to detect low viral loads. PCR assays enable rapid, reliable detection of hMPV, even in early stages of infection, leading to faster diagnosis, better patient outcomes, and enhanced control of viral transmission, especially in high-risk populations.
  • Based on end use, diagnostic and reference laboratories segment is expected to grow at the fastest CAGR over the forecast period driven by increasing demand for specialized testing, faster diagnostic results, and more accurate disease detection. These laboratories provide essential services for identifying hMPV and other respiratory infections, supporting both clinical and research settings.
  • Based on region, North America market dominated the overall global market and accounted for the 41.18% revenue share in 2024 driven by the increasing due to higher awareness, advanced healthcare infrastructure, and increased prevalence of respiratory infections.
  • The competitive scenario in the Human Metapneumovirus (hMPV) diagnostics market is high. The major companies are undertaking various strategies such as collaborations, new product development, mergers, acquisitions, and geographic expansion for serving the unmet needs of their customers.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Technology Segment
    • 1.2.2. End-use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Global Human Metapneumovirus (hMPV) Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising prevalence of respiratory infections
      • 3.2.1.2. Advancements in molecular diagnostic
      • 3.2.1.3. Growing awareness among healthcare providers
      • 3.2.1.4. Supportive regulatory approvals and guidelines
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High costs of advanced diagnostics tests
      • 3.2.2.2. Limited awareness in developing regions
  • 3.3. Global Human Metapneumovirus (hMPV) Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Global Human Metapneumovirus (hMPV) Diagnostics Market: Technology Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Human Metapneumovirus (hMPV) Diagnostics Market Technology Movement Analysis
  • 4.3. Global Human Metapneumovirus (hMPV) Diagnostics Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 4.4. PCR-Based Diagnostics
    • 4.4.1. PCR-based diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.5. Next-Generation Sequencing (NGS)
    • 4.5.1. Next-Generation Sequencing (NGS) market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.6. Immunofluorescence Assays
    • 4.6.1. Immunofluorescence assays market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.7. Lateral Flow Assays
    • 4.7.1. Lateral flow assays market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.8. Microarray Technology
    • 4.8.1. Microarray technology market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.9. Other Advanced Technologies
    • 4.9.1. Other advanced technologies market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5. Global Human Metapneumovirus (hMPV) Diagnostics Market: End-use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Human Metapneumovirus (hMPV) Diagnostics Market End-use Movement Analysis
  • 5.3. Global Human Metapneumovirus (hMPV) Diagnostics Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals and Clinics
    • 5.4.1. Hospitals and clinics market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Diagnostic and Reference Laboratories
    • 5.5.1. Diagnostic and reference laboratories market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Academic and Research Institutions
    • 5.6.1. Academic and research institutions market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Human Metapneumovirus (hMPV) Diagnostics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Dashboard
  • 6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.3. North America
    • 6.3.1. U.S.
      • 6.3.1.1. Key country dynamics
      • 6.3.1.2. Regulatory framework/ reimbursement structure
      • 6.3.1.3. Competitive scenario
      • 6.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.2. Canada
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.3. Mexico
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.6. Norway
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. India
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Argentina
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2023
  • 7.4. List of Key Certification Providers/Scheme Owners
  • 7.5. Company Profiles/Listing
    • 7.5.1. QuidelOrtho Corporation
      • 7.5.1.1. Company overview
      • 7.5.1.2. Financial performance
      • 7.5.1.3. Product benchmarking
      • 7.5.1.4. Strategic initiatives
    • 7.5.2. ARUP Laboratories
      • 7.5.2.1. Company overview
      • 7.5.2.2. Financial performance
      • 7.5.2.3. Product benchmarking
      • 7.5.2.4. Strategic initiatives
    • 7.5.3. Diasorin
      • 7.5.3.1. Company overview
      • 7.5.3.2. Financial performance
      • 7.5.3.3. Product benchmarking
      • 7.5.3.4. Strategic initiatives
    • 7.5.4. R-Biopharm AG
      • 7.5.4.1. Company overview
      • 7.5.4.2. Financial performance
      • 7.5.4.3. Product benchmarking
      • 7.5.4.4. Strategic initiatives
    • 7.5.5. Seegene Inc.
      • 7.5.5.1. Company overview
      • 7.5.5.2. Financial performance
      • 7.5.5.3. Product benchmarking
      • 7.5.5.4. Strategic initiatives
    • 7.5.6. ZeptoMetrix
      • 7.5.6.1. Company overview
      • 7.5.6.2. Financial performance
      • 7.5.6.3. Product benchmarking
      • 7.5.6.4. Strategic initiatives
    • 7.5.7. Abbott
      • 7.5.7.1. Company overview
      • 7.5.7.2. Financial performance
      • 7.5.7.3. Product benchmarking
      • 7.5.7.4. Strategic initiatives
    • 7.5.8. Thermo Fisher Scientific Inc.
      • 7.5.8.1. Company overview
      • 7.5.8.2. Financial performance
      • 7.5.8.3. Product benchmarking
      • 7.5.8.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 4 Global Human Metapneumovirus (hMPV) diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 5 Global Human Metapneumovirus (hMPV) diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America Human Metapneumovirus (hMPV) diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 8 North America Human Metapneumovirus (hMPV) diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 U.S. Human Metapneumovirus (hMPV) diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 U.S. Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 11 Canada Human Metapneumovirus (hMPV) diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Canada Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 13 Europe Human Metapneumovirus (hMPV) diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 14 Europe Human Metapneumovirus (hMPV) diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Europe Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 16 UK Human Metapneumovirus (hMPV) diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 UK Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Germany Human Metapneumovirus (hMPV) diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Germany Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 20 France Human Metapneumovirus (hMPV) diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 21 France Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 22 Italy Human Metapneumovirus (hMPV) diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Italy Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 24 Spain Human Metapneumovirus (hMPV) diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Spain Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 26 Sweden Human Metapneumovirus (hMPV) diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 27 Sweden Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 28 Denmark Human Metapneumovirus (hMPV) diagnostics market, by end-use type, 2018 - 2030 (USD Million)
  • Table 29 Denmark Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 30 Norway Human Metapneumovirus (hMPV) diagnostics market, by end-use type, 2018 - 2030 (USD Million)
  • Table 31 Norway Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific Human Metapneumovirus (hMPV) diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific Human Metapneumovirus (hMPV) diagnostics market, by end-use type, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 35 Japan Human Metapneumovirus (hMPV) diagnostics market, by end-use type, 2018 - 2030 (USD Million)
  • Table 36 Japan Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 37 India Human Metapneumovirus (hMPV) diagnostics market, by end-use type, 2018 - 2030 (USD Million)
  • Table 38 India Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 39 China Human Metapneumovirus (hMPV) diagnostics market, by end-use type, 2018 - 2030 (USD Million)
  • Table 40 China Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 41 Australia Human Metapneumovirus (hMPV) diagnostics market, by end-use type, 2018 - 2030 (USD Million)
  • Table 42 Australia Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 43 South Korea Human Metapneumovirus (hMPV) diagnostics market, by end-use type, 2018 - 2030 (USD Million)
  • Table 44 South Korea Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 45 Thailand Human Metapneumovirus (hMPV) diagnostics market, by end-use type, 2018 - 2030 (USD Million)
  • Table 46 Thailand Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 47 Latin America Human Metapneumovirus (hMPV) diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 48 Latin America Human Metapneumovirus (hMPV) diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Latin America Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 50 Brazil Human Metapneumovirus (hMPV) diagnostics market, by end-use types, 2018 - 2030 (USD Million)
  • Table 51 Brazil Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 52 Mexico Human Metapneumovirus (hMPV) diagnostics market, by end-use type, 2018 - 2030 (USD Million)
  • Table 53 Mexico Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 54 Argentina Human Metapneumovirus (hMPV) diagnostics market, by end-use type, 2018 - 2030 (USD Million)
  • Table 55 Argentina Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa Human Metapneumovirus (hMPV) diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa Human Metapneumovirus (hMPV) diagnostics market, by end-use type, 2018 - 2030 (USD Million)
  • Table 58 Middle East & Africa Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 59 South Africa Human Metapneumovirus (hMPV) diagnostics market, by end-use type, 2018 - 2030 (USD Million)
  • Table 60 South Africa Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia Human Metapneumovirus (hMPV) diagnostics market, by end-use type, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 63 UAE Human Metapneumovirus (hMPV) diagnostics market, by end-use type, 2018 - 2030 (USD Million)
  • Table 64 UAE Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 65 Kuwait Human Metapneumovirus (hMPV) diagnostics market, by end-use type, 2018 - 2030 (USD Million)
  • Table 66 Kuwait Human Metapneumovirus (hMPV) diagnostics market, by technology, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Human Metapneumovirus (hMPV) diagnostics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Human Metapneumovirus (hMPV) diagnostics market driver analysis
  • Fig. 13 Human Metapneumovirus (hMPV) diagnostics market restraint analysis
  • Fig. 14 Human Metapneumovirus (hMPV) diagnostics market: Porter's analysis
  • Fig. 15 Human Metapneumovirus (hMPV) diagnostics market: PESTLE analysis
  • Fig. 16 Human Metapneumovirus (hMPV) diagnostics market: Technology outlook and key takeaways
  • Fig. 17 Human Metapneumovirus (hMPV) diagnostics market: Technology market share analysis, 2024 - 2030
  • Fig. 18 PCR-based diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 19 Next-Generation Sequencing (NGS) market, 2018 - 2030 (USD Million)
  • Fig. 20 Immunofluorescence assays market, 2018 - 2030 (USD Million)
  • Fig. 21 Lateral flow assays market, 2018 - 2030 (USD Million)
  • Fig. 22 Microarray technology market, 2018 - 2030 (USD Million)
  • Fig. 23 Other advanced technologies market, 2018 - 2030 (USD Million)
  • Fig. 24 Human Metapneumovirus (hMPV) diagnostics market: End-use outlook and key takeaways
  • Fig. 25 Human Metapneumovirus (hMPV) diagnostics market: End-use market share analysis, 2024 - 2030
  • Fig. 26 Hospitals and clinics
  • Fig. 27 Diagnostic and reference laboratories
  • Fig. 28 Academic and research institutions
  • Fig. 29 Others market, 2018 - 2030 (USD Million)
  • Fig. 30 Regional marketplace key takeaways
  • Fig. 31 North America Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. key country dynamics
  • Fig. 34 Canada Human Metapneumovirus (hMPV) diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 35 Canada key country dynamics
  • Fig. 36 Mexico Human Metapneumovirus (hMPV) diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 37 Mexico key country dynamics
  • Fig. 38 Europe Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 UK Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 UK key country dynamics
  • Fig. 41 Germany Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Germany key country dynamics
  • Fig. 43 France Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 France key country dynamics
  • Fig. 45 Italy Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Italy key country dynamics
  • Fig. 47 Spain Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Spain key country dynamics
  • Fig. 49 Denmark Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Denmark key country dynamics
  • Fig. 51 Sweden Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Sweden key country dynamics
  • Fig. 53 Norway Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Norway key country dynamics
  • Fig. 55 Asia-Pacific Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Japan Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Japan key country dynamics
  • Fig. 58 China Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 China key country dynamics
  • Fig. 60 India Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 India key country dynamics
  • Fig. 62 Australia Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Australia key country dynamics
  • Fig. 64 Thailand Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Thailand key country dynamics
  • Fig. 66 South Korea Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 South Korea key country dynamics
  • Fig. 68 Latin America Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Brazil Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Brazil key country dynamics
  • Fig. 71 Argentina Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Argentina key country dynamics
  • Fig. 73 MEA Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 South Africa Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 South Africa key country dynamics
  • Fig. 76 Saudi Arabia Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Saudi Arabia key country dynamics
  • Fig. 78 UAE Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 UAE key country dynamics
  • Fig. 80 Kuwait Human Metapneumovirus (hMPV) diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Kuwait key country dynamics
  • Fig. 82 Key company categorization
  • Fig. 83 Company market share analysis
  • Fig. 84 Company market position analysis
  • Fig. 85 Market participant categorization
  • Fig. 86 Strategy framework